LIGAND PHARMACEUTICAL ($LGND) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of -$1.64 per share, missing estimates of $1.21 by $2.85. The company also reported revenue of $42,810,000, beating estimates of $39,803,082 by $3,006,918.
You can see Quiver Quantitative's $LGND stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LIGAND PHARMACEUTICAL Insider Trading Activity
LIGAND PHARMACEUTICAL insiders have traded $LGND stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $LGND stock by insiders over the last 6 months:
- MATTHEW E KORENBERG (President & COO) has made 0 purchases and 4 sales selling 16,047 shares for an estimated $1,642,358.
- OCTAVIO ESPINOZA (Chief Financial Officer) has made 0 purchases and 4 sales selling 3,379 shares for an estimated $377,368.
- JOHN L LAMATTINA sold 2,406 shares for an estimated $297,501
- ANDREW REARDON (CLO & Secretary) sold 2,000 shares for an estimated $199,201
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LIGAND PHARMACEUTICAL Hedge Fund Activity
We have seen 138 institutional investors add shares of LIGAND PHARMACEUTICAL stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 276,731 shares (+inf%) to their portfolio in Q4 2024, for an estimated $29,651,726
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 205,689 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $22,039,576
- VILLERE ST DENIS J & CO LLC removed 187,814 shares (-39.6%) from their portfolio in Q4 2024, for an estimated $20,124,270
- VANGUARD GROUP INC added 115,005 shares (+5.8%) to their portfolio in Q4 2024, for an estimated $12,322,785
- FRANKLIN RESOURCES INC added 90,743 shares (+95.9%) to their portfolio in Q4 2024, for an estimated $9,723,112
- KNOTT DAVID M JR removed 85,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $8,507,650
- F/M INVESTMENTS LLC removed 81,416 shares (-60.6%) from their portfolio in Q4 2024, for an estimated $8,723,724
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
